MIRA INFORM REPORT

 

 

Report Date :

25.09.2014

 

IDENTIFICATION DETAILS

 

Name :

WOCKHARDT LIMITED

 

 

Registered Office :

Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai – 400051, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

08.07.1999

 

 

Com. Reg. No.:

11-120720

 

 

Capital Investment / Paid-up Capital :

Rs. 3534.300 Millions

 

 

CIN No.:

[Company Identification No.]

L24230MH1999PLC120720

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

NSKW00152F

 

 

PAN No.:

[Permanent Account No.]

AAACW2472M

 

 

Legal Form :

A Public Limited Liability company. The company’s Shares are Listed on the Stock Exchanges.

 

 

Line of Business :

Subject engaged in the business of Manufacture and Marketing of Pharmaceutical Products.

 

 

No. of Employees :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

A (60)

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 49000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Exist

 

 

Comments :

Subject is a well-established company having fine track record.

 

There is drastic dip in the profit of the company during 2014. However, general financial position of the company seems to be sound and healthy.

 

Trade relations are fair. Business is active. Payment terms are reported to be regular and as per commitments.

 

The company can be considered good for business dealings at usual trade terms and conditions. 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

N E W S

 

Verdict Implications: Apex court order may alter coal import dynamics. Traders go slow on talks over coal supply contracts, uncertainty over cancellation of blocks weigh on stocks.

 

Recent arrest of the Chennai head of the Registrar of Companies, the ministry of corporate affairs arm that ensures that companies file all the information required by the Companies Act is the latest manifestation of a messy fight between a father and his adopted son for the control of Rs 40000 mn business empire. The Central Bureau of Investigation arrested Manumeethi Cholan after he accepted Rs 10 lakhs as bribe from M A M Ramaswamy, a CBI official said.

 

Central Bureau of Investigation books Electrotherm for cheating Central Bank of Rs 4360 mn.

 

Infosys maintains revenue guidance. COO Rao says attrition still an area of concern and it would take a few more quarters to bring down levels to 13-15 %.

 

DHL  to invest Euro 100 mn in India over next 2 years. The firm has chosen India to pilot its e-commerce business model for the Asia-Pacific region.

 

Blackstone may buy stake in BlueRidge SEZ in line with the fund’s real estate strategy in India.

 

Kingfisher Airlines Ltd grounded in October 2012 under the weight of heavy debt and accumulated losses, recently approached the Delhi high court for relief in two separate cases. The airline challenged a notice by Punjab & National Bank alleging that It had wilfully defaulted on Rs 7700 mn of loans and sought more time to comply with the requirements under the listing agreements with the Stock Exchanges.

 

OnMobile likely to sack another 300 employees. The lay-offs follow a spate of senior-level exits over the past two years, starting with of its founder. The overall lay-offs could number around 600 and are driven by the need to cut costs, says a former employee.

 

 

EXTERNAL AGENCY RATING

 

Rating Agency Name

CARE

Rating

Long Term Bank Facilities = AA-

Rating Explanation

Have degree of safety and carry very low credit risk

Date

21.02.2014

 

Rating Agency Name

CARE

Rating

Short Term Bank Facilities = A1+

Rating Explanation

Have very strong degree of safety and carry lowest credit risk

Date

21.02.2014

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2014.

 

 

LOCATIONS

 

Registered / Corporate Office :

Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai – 400051, Maharashtra, India

Tel. No.:

91-22-26534444 / 26533333 / 26522727

Fax No.:

91-22-26522727 / 26522828 / 26534242

E-Mail :

wock@giasbm01.vsnl.net.in

wockhard@giasbm01.vsnl.net.in

ocassubhoy@wockhardtin.com

spathak@wockhardt.com

contactus@wockhardt.com

jmanmadkar@wockhardt.com

cpatodi@wackhardt.com

Website :

www.wockhardt.com

 

 

Factory 1 :

Wockhardt Biotech Park, H14/2 M.I.D.C., Area Waluj, Aurangabad - 431136, Maharashtra, India

Tel. No.:

91-240-6626444

Fax No.:

91 240 6626333

 

 

Factory 2 :

L1 M.I.D.C., Chikalthana, Aurangabad - 431210, Maharashtra, India

Tel. No.:

91-240-6637444

Fax No.:

91-240-6637333

 

 

Factory 3 :

87A, Silver Industrial Estate, Bhimpore, Nani Daman - 396210, Union Territory, India

Tel. No.:

91-260-6610300 / 6610333

Fax No.:

91-260-2220940

 

 

Factory 4 :

106/4,5,7 Kadaiya, Nani Daman 396210, Union Territory India

Tel. No.:

91260-6531306

Fax No.:

91-260-2220214

 

 

Factory 5 :

138 G.I.D.C. Estate, Ankleshwar 393002, District Bharuch, Gujarat, India

Tel. No.:

91-2646-661444

Fax No.:

91-2646-661555

 

 

Factory 6 :

P O Barotiwala, District Solan, Himachal Pradesh 174103, India

Tel. No.:

91-1795-664444

Fax No.:

91-1795-664242

 

 

Factory 7 :

Ash Raod North, Wexham Industrial Estate, Wrexham, LL13 9UF, Wales, UK

Tel. No.:

+44-1978-661261

Fax No.:

+44-1978-660130

 

 

Factory 8 :

Ballymacarbry Clonmel Co., Tippearary, Ireland

Tel. No.:

+353-52-6186000

Fax No.:

+353-52-6136311

 

 

Factory 9 :

6451, Main Street, Morton Frove, III Inois 60053-2633, USA

Tel. No.:

+1-847+9675600

Fax No.:

+1-847-9672211

 

 

Factory 10 :

B-15/2, MIDC Waluj-431136, Maharashtra, India 

Tel. No.:

91-240-6636400

Fax No.:

91-240-6636444

 

 

International Office :

Located At:

 

  • USA
  • UK
  • Ireland
  • Switzerland

 

 

Research Centers  :

Located At:

 

  • India
  • UK
  • USA

 

 

DIRECTORS

 

As on: 31.03.2014

 

Name :

Dr. Habil Khorakiwala

Designation :

Chairman

 

 

Name :

Dr. Huzaifa Khorakiwala

Designation :

Executive Director

 

 

Name :

Dr. Murtaza Khorakiwala

Designation :

Managing Director

 

 

Name :

Mr. Shekhar Datta

Designation :

Director

 

 

Name :

Mr. Aman Mehta

Designation :

Director

 

 

Name :

Mr. R A Shah

Designation :

Director

 

 

Name :

Mr. D. S. Brar

Designation :

Director

 

 

Name :

Mr. Sanjaya Baru

Designation :

Director

 

 

KEY EXECUTIVES

 

Name :

Mr. V R Khetan

Designation :

Secretary

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on: 30.06.2014

 

Category of Shareholder

No. of Shares

Percentage of Holding

(A) Shareholding of Promoter and Promoter Group

 

 

http://www.bseindia.com/include/images/clear.gif(1) Indian

 

 

http://www.bseindia.com/include/images/clear.gifIndividuals / Hindu Undivided Family

887625

0.81

http://www.bseindia.com/include/images/clear.gifBodies Corporate

81097757

73.82

http://www.bseindia.com/include/images/clear.gifSub Total

81985382

74.63

http://www.bseindia.com/include/images/clear.gif(2) Foreign

 

 

Total shareholding of Promoter and Promoter Group (A)

81985382

74.63

(B) Public Shareholding

 

 

http://www.bseindia.com/include/images/clear.gif(1) Institutions

 

 

http://www.bseindia.com/include/images/clear.gifMutual Funds / UTI

1197218

1.09

http://www.bseindia.com/include/images/clear.gifFinancial Institutions / Banks

2046610

1.86

http://www.bseindia.com/include/images/clear.gifInsurance Companies

1400

0.00

http://www.bseindia.com/include/images/clear.gifForeign Institutional Investors

6115775

5.57

http://www.bseindia.com/include/images/clear.gifSub Total

9361003

8.52

http://www.bseindia.com/include/images/clear.gif(2) Non-Institutions

 

 

http://www.bseindia.com/include/images/clear.gifBodies Corporate

2977228

2.71

http://www.bseindia.com/include/images/clear.gifIndividuals

 

 

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital up to Rs. 0.100 million

12796681

11.65

http://www.bseindia.com/include/images/clear.gifIndividual shareholders holding nominal share capital in excess of Rs. 0.100 million

974546

0.89

http://www.bseindia.com/include/images/clear.gifAny Others (Specify)

1762530

1.60

http://www.bseindia.com/include/images/clear.gifClearing Members

805293

0.73

http://www.bseindia.com/include/images/clear.gifNon Resident Indians

822770

0.75

http://www.bseindia.com/include/images/clear.gifTrusts

1867

0.00

http://www.bseindia.com/include/images/clear.gifDirectors & their Relatives & Friends

132600

0.12

http://www.bseindia.com/include/images/clear.gifSub Total

18510985

16.85

Total Public shareholding (B)

27871988

25.37

Total (A)+(B)

109857370

100.00

(C) Shares held by Custodians and against which Depository Receipts have been issued

0

0.00

http://www.bseindia.com/include/images/clear.gif(1) Promoter and Promoter Group

0

0.00

http://www.bseindia.com/include/images/clear.gif(2) Public

150533

0.00

http://www.bseindia.com/include/images/clear.gifSub Total

150533

0.00

Total (A)+(B)+(C)

110007903

0.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Subject engaged in the business of Manufacture and Marketing of Pharmaceutical Products.

 

 

Exports :

 

Products :

Not Divulged

Countries :

Not Divulged

 

 

Imports :

 

Products :

Not Divulged

Countries :

Not Divulged

 

 

GENERAL INFORMATION

 

Suppliers :

Not Divulged

 

 

Customers :

Not Divulged

 

 

No. of Employees :

Not Available

 

 

Bankers :

·         ICICI Bank

·         State Bank of India

 

 

Facilities :

(Rs. In Millions)

Secured Loan

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWINGS

 

 

Rupee Denominated Term Loans from others

9.700

18.800

 

 

 

SHORT TERM BORROWINGS

 

 

Working capital facilities from banks

1632.300

1631.700

 

 

 

Total

1642.000

1650.500

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Haribhakti and Company

Chartered Accountants

 

 

Holding Company :

  • Khorakiwala Holdings and Investments Private Limited

 

 

Associates :

  • Swiss Biosciences AG

 

 

Wholly Owned Subsidiaries :

  • Wockhardt UK Holdings Limited (formerly, Wockhardt UK Limited)
  • CP Pharmaceuticals Limited
  • CP Pharma (Schweiz) AG
  • Wallis Group Limited
  • The Wallis Laboratory Limited
  • Wockhardt Farmaceutica Do Brasil Ltda
  • Wallis Licensing Limited
  • Wockhardt Biopharm Limited
  • Vinton Healthcare Limited
  • Wockhardt Infrastructure Development Limited
  • Z and Z Services GmbH (formerly, esparma GmbH)
  • Wockhardt Europe Limited
  • Wockhardt Nigeria Limited
  • Wockhardt USA LLC w.e.f. October 3, 2008 (formerly, Wockhardt USA Inc.,)
  • Wockhardt Bio AG (Formerly Wockhardt EU Operations (Swiss) AG)
  • Wockhardt UK Limited
  • Wockhardt Cyprus Limited
  • Wockpharma Ireland Limited
  • Pinewood Laboratories Limited
  • Pinewood healthcare Limited
  • Nonash Limited
  • Laboratoires Negma S.A.S. (formerly, Negma Lerads S.A.S.)
  • Wockhardt France (Holdings) S.A.S.
  • Esparma AG
  • Wockhardt Holding Corp
  • Morton Grove Pharmaceuticals, Inc.
  • MGP Inc.
  • Girex S.A.S. (liquidated on October 6, 2011)
  • Mazal Pharmaceutique S.A.R.L. (liquidated on October 6, 2011)
  • Laboratoires Pharma 2000 S.A.S. (formerly, Pharma 2000 S.A.S.)
  • Hariphar S.C.
  • Niverpharma S.A.S.
  • Negma Beneulex S.A.
  • S.C.I. Salome
  • Phytex S.A.S.
  • Scomedia S.A.S. (sold on May 16, 2011)
  • Laboratoires Lerads S.A.S. (Merged on November 28, 2012)
  • Wockhardt Farmaceutica SA DE CV. (w.e.f. November 9, 2012)
  • Wockhardt Services SA DE CV. (w.e.f. June 21, 2012)

 

 

Fellow Subsidiary :

·         Carol Info Services Limited

 

 

Other Related Parties :

·         Palanpur Holdings and Investments Private Limited

·         Wockhardt Hospitals Limited

·         Merind Limited

·         Wockhardt Foundation

·         Dartmour Holdings Private Limited

 

 

CAPITAL STRUCTURE

 

As on: 31.03.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

250000000

Equity Shares

Rs.5/- each

Rs. 1250.000 Millions

2000000000

Preference Shares

Rs.5/- each

Rs. 10000.000 Millions

 

TOTAL

 

Rs. 11250.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

109435903

Equity Shares

Rs.5/- each

Rs. 547.200 Millions

167750

Add : Shares Issued during the year Pursuant to ESOS

 

Rs. 0.900 Million

121454927

Optionally Convertible Cumulative Redeemable Preference Shares

Rs.5/- each

Rs. 607.200 Millions

475659941

Non-Convertible Cumulative Redeemable Preference Shares

Rs.5/- each

Rs. 2378.300 Millions

 

 

 

 

 

TOTAL

 

Rs. 3534.300 Millions

 

 

LISTING DETAILS:

 

 

Subject Stock Code :

 

BSE : 532300

 

NSE : WOCKPHARMAEQ

 

 

Stock Exchange Place :

 

Ř       National Stock Exchange of India Limited

Ř       The Stock Exchange, Mumbai

 

 

Listed Date :

 

Not Divulged

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.        EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

3534.300

3533.400

8160.900

(b) Reserves & Surplus

8821.300

7633.800

654.900

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

0.000

Total Shareholders’ Funds (1) + (2)

12355.600

11167.200

8815.800

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

70.000

95.200

7415.200

(b) Deferred tax liabilities (Net)

1367.000

1205.500

2051.400

(c) Other long term liabilities

6286.300

0.000

0.000

(d) long-term provisions

280.500

260.800

289.000

Total Non-current Liabilities (3)

8003.800

1561.500

9755.600

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

1744.400

1631.700

2222.800

(b) Trade payables

3306.900

4693.000

3695.300

(c) Other current liabilities

8231.800

11746.500

6943.300

(d) Short-term provisions

271.100

873.300

211.500

Total Current Liabilities (4)

13554.200

18944.500

13072.900

 

 

 

 

TOTAL

33913.600

31673.200

31644.300

 

 

 

 

II.      ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

9943.600

8768.600

8212.500

(ii) Intangible Assets

385.200

597.600

347.100

(iii) Capital work-in-progress

5818.300

4817.900

4736.600

(iv) Intangible assets under development

0.000

0.000

3371.400

(b) Non-current Investments

3079.500

3079.500

3079.500

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d) Long-term Loan and Advances

3723.200

3429.200

2941.600

(e) Other Non-current assets

1061.900

49.200

0.000

Total Non-Current Assets

24011.700

20742.000

22688.700

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

4844.600

5275.900

4530.700

(c) Trade receivables

2463.600

2066.300

2608.400

(d) Cash and cash equivalents

857.900

1839.300

759.400

(e) Short-term loans and advances

1735.800

1749.700

1057.100

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

9901.900

10931.200

8955.600

 

 

 

 

TOTAL

33913.600

31673.200

31644.300

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

18052.700

24711.800

22971.000

 

 

Other Income

3193.800

455.000

199.700

 

 

TOTAL                                     (A)

21246.500

25166.800

23170.700

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Cost of Materials Consumed

5133.100

8593.000

6702.900

 

 

Purchases of Stock-in-Trade

2809.600

2614.300

2365.300

 

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

47.100

3010.700

2182.900

 

 

Employees benefits expense

3545.300

5609.700

4812.300

 

 

Exchange Fluctuation Loss / (Gain) Net

406.400

(2881.800)

1616.500

 

 

Other expenses

5857.500

(829.500)

(843.900)

 

 

TOTAL                                     (B)

17799.000

-198.400

270.500

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

3447.500

25365.200

22900.200

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

336.700

1543.700

2153.600

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

3110.800

23821.500

20746.600

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

963.200

807.700

663.100

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

2147.600

23013.800

20083.500

 

 

 

 

 

Less

TAX                                                                  (H)

161.500

(829.800)

(1863.200)

 

 

 

 

 

 

Profit for the year from Continuing Operations

0.000

6067.600

1384.300

 

 

 

 

 

 

Profit for the discontinued operations (before tax)

0.000

236.000

589.600

 

 

 

 

 

 

Tax expenses of discounted operations

0.000

(76.600)

(133.900)

 

 

 

 

 

 

Profit from discontinued operations

0.000

159.400

455.700

 

 

 

 

 

 

PROFIT / (LOSS) AFTER TAX

1986.100

6227.000

1840.000

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Exports of goods on F.O.B. basis

 

11740.400

12094.400

 

 

Management and Technical fees

 

57.800

128.100

 

 

Out licensing fees

 

1677.700

1400.000

 

 

Royalty

 

31.100

7.300

 

 

Interest

 

34.800

31.400

 

 

Research and Development Services

 

40.600

101.900

 

 

Assignment of New Chemical Entity

 

1000.000

0.000

 

 

Others

 

0.000

26.000

 

TOTAL EARNINGS

11025.600

14582.400

13789.100

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

 

2538.200

2314.900

 

 

Component and Spares

 

44.900

217.900

 

 

Capital Goods

 

260.200

366.400

 

TOTAL IMPORTS

3760.100

2843.300

2899.200

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

18.10

56.88

16.81

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

PAT / Total Income

(%)

9.35

94.74

94.72

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

11.90

93.13

87.43

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

8.58

96.80

98.18

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.17

2.06

2.28

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.15

0.15

1.09

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

0.73

0.58

0.69

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Millions]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Share Capital

8160.900

3533.400

3534.300

Reserves & Surplus

654.900

7633.800

8821.300

Net worth

8815.800

11167.200

12355.600

 

 

 

 

long-term borrowings

7415.200

95.200

70.000

Short term borrowings

2222.800

1631.700

1744.400

Total borrowings

9638.000

1726.900

1814.400

Debt/Equity ratio

1.093

0.155

0.147

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

22971.000

24711.800

18052.700

 

 

7.578

(26.947)

 

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Millions)

(Rs. In Millions)

(Rs. In Millions)

Sales

22971.000

24711.800

18052.700

Profit

21946.700

23843.600

1986.100

 

95.54%

96.49%

11.00%

 

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check List by Info Agents

Available in Report (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

No

9]

Name of person contacted

No

10]

Designation of contact person

No

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

--

14]

Estimation for coming financial year

No

15]

Capital in the business

Yes

16]

Details of sister concerns

Yes

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

No

20]

Export / Import details (if applicable)

No

21]

Market information

--

22]

Litigations that the firm / promoter involved in

Yes

23]

Banking Details

Yes

24]

Banking facility details

Yes

25]

Conduct of the banking account

--

26]

Buyer visit details

--

27]

Financials, if provided

Yes

28]

Incorporation details, if applicable

Yes

29]

Last accounts filed at ROC

Yes

30]

Major Shareholders, if available

Yes

31]

Date of Birth of Proprietor/Partner/Director, if available

No

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

Yes

 

 

UNSECURED LOAN

(Rs. In Millions)

Particulars

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWINGS

 

 

Sales tax deferral loan

21.200

31.000

Loans from Others

39.100

45.400

 

 

 

SHORT TERM BORROWINGS

 

 

Buyers’ credit

112.100

0.000

 

 

 

Total

172.400

76.400

 

LITIGATION DETAILS:

 

Case Details

 

Bench:-Bombay

 

Lodging No.:-

NMSL/197/2014

Filing Date:-

29.01.2014

 

Main Matter

 

Lodging No.:-

Sl/3957/998

Reg No.:-

S/4077/1998

 

 

Petitioner :

CAUVERY SOFTWARE ENGG. SYSTEMS LIMITED

Respondent:-

WOCKHARDT LIMITED AND ORS.

Petn. Adv.:

RAHUL SHANKAR ARPOTE (I2585)

 

 

 

District:- MUMBAI

 

Bench:- DIVISION    

                                 

Status:- Pre-Admission                                                  Category:- NOTICE OF MOTION

 

Last Date : 05/02/2014

 

Last Coram: ACCORDING TO SITTING LIST 

 

Act : Code of civil procedure 1908

 

 

STATEMENT OF STANDALONE UNAUDITED RESULTS FOR THE QUARTER ENDED JUNE 30, 2014

(Rs. In Millions)

Sr.

No.

 

Particulars

Quarter Ended

 

30.06.2014

(Unaudited)

 

Income from operations

 

 

Net Sales/Income from Operations

4854.400

 

Other operating income

0.000

 

Total Income from Operations (Net)

4854.400

 

 

 

 

Expenditure

 

 

Cost of Materials Consumed

1175.900

 

Purchases of Stock-in-Trade

931.100

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

-97.300

 

Employees benefits expense

967.500

 

Depreciation

247.000

 

Other expenditure

1562.900

 

Total Expenses

4787.100

 

 

 

 

Profit From Operations before Other Income, Interest and Exceptional Items (1-2)

67.300

 

Other Income

47.500

 

Exchange fluctuation

29.600

 

Profit from Ordinary Activities before Finance Cost and Exceptional Items (3+4)

85.200

 

Finance Cost

49.300

 

Profit from Ordinary Activities after Finance Cost but before provision for Onerous Contracts and Exceptional Items (5+6)

35.900

 

Exceptional Items

0.000

 

Profit /(Loss) from ordinary activities before tax (7-8)

35.900

 

Tax Expense

-17.600

 

Net Profit from Ordinary Activities after tax (9+10)

53.500

 

Extraordinary Items

0.000

 

Net profit for the period (11+12) from continuing operations

53.500

 

Profit from Discontinuing operations before tax

0.000

 

Tax on Discontinuing operations

0.000

 

Profit after tax from discounting operations (14a+14b)

0.000

 

Net Profit/ (Loss) from ordinary activities after tax (9-10)

0.000

 

 Paid-up Equity Share Capital (Rs. 5/- Per Share)

53.500

 

Reserves Excluding Revaluation Reserve per Balance Sheet of the previous accounting
year

550

 

EPS before Extraordinary items

 

 

Basic

0.49*

 

Diluted

0.49*

 

 

 

 

Public Shareholding

 

 

-Number of Shares

27871988

 

- Percentage of Shareholding

25.34%

 

Promoters and Promoter Group Shareholding

 

 

a) Pledged/Encumbered

 

 

- Number of Shares

0

 

- Percentage of Shares (as a % of the Total Shareholding of promoter and promoter group)

0.00%

 

- Percentage of Shares (as a % of the Total Share Capital of the Company)

0.00%

 

b) Non Encumbered

 

 

- Number of Shares

81985382

 

- Percentage of Shares (as a % of the Total Shareholding of Promoter and Promoter Group)

100.00%

 

- Percentage of Shares (as a % of the Total Share Capital of the Company)

74.53%

 

 

Particulars

30.06.2014

Investment Complaints

 

Pending at the beginning of the quarter

0

Received during the quarter

0

Disposed of during the quarter

0

Remaining unresolved at the end of the quarter

0

 

Note:

 

The results were reviewed by the Audit Committee and approved by the Board of Directors at their meetings held on August 12, 2014.


During the quarter, the Company has issued and allotted 256,750 equity shares of face value of Rs. 5 each pursuant to exercise of employee stock options.


During the quarter, the Company has reviewed the useful life of its tangible assets as required under Schedule II of the Companies Act 2013, according to which useful life estimated earlier are found to be appropriate. Hence, there is no impact on the profits for the quarter. The Company has also identified significant components and their useful life which will be depreciated over the balance useful life effective April 01, 2014. As a result of above, depreciation charge for the quarter is higher by Rs. 21.900 millions Further, in respect of assets with revised useful life as nil, the carrying amount of assets (net of deferred tax) has been charged to the opening reserves as on April 01, 2014 pursuant to the Companies Act, 2013.


The Company is exclusively into Pharmaceutical business Segment.


Figures for the quarter ended March 31, 2014 are the balancing figures between the audited figures in respect of the full financial year and the unaudited published figures up to the third quarter of the relevant financial year.


Previous period figures have been recast/ re-classified to conform to the current period's presentation.

 

INDEX OF CHARGE:

 

Sr. No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10253301

07/12/2011 *

26,152,000.00

Department Of Biotechnology

6-8th Floor, Block No. 2, CGO Complex, Lodhi Road, New Delhi, Delhi - 110003, India

B27629591

2

10239938

15/03/2011 *

16,412,700,000.00

Sbicap Trustee Company Limited

202, Maker Tower, 'E', Cuffe Parade, Colaba, Mumbai, Maharashtra - 400005, India

B09941931

3

10240003

31/08/2010

16,932,800,000.00

Sbicap Trustee Company Limited

202, Maker Tower, 'E', Cuffe Parade, Colaba, Mumbai, Maharashtra - 400005, India

A94607587

4

10238614

18/08/2010

29,864,500,000.00

State Bank of India

Capital Market Branch, Videocon Heritage, Ground
Floor, Charanjit Rai Marg, Mumbai, Maharashtra - 400001, India

A92103076

5

10225953

29/06/2010

4,667,210,000.00

Sbicap Trustee Company Limited

202, Maker Tower, 'E', Cuffe Parade, Colaba, Mumbai, Maharashtra - 400005, India

A88114897

6

10195016

23/11/2009

484,900,000.00

HDFC Bank Limited

HDFC Bank House Senapati Bapat Marg, Lower Parel W, Mumbai, Maharashtra - 400013, India

A76885995

7

10192780

23/11/2009

2,990,100,000.00

ICICI Bank Limited

Landmarkrace Cource Circle, Alkapuri, Baroda, Gujarat - 390015, India

A75404855

8

10199434

23/11/2009

3,820,000,000.00

State Bank of India

Corporate Accounts Group Branch, Voltas Hose, 23, J.N. Heredia Marg, Mumbai, Maharashtra - 400001, India

A76706431

9

10038845

08/02/2007

11,250,000,000.00

State Bank of India

New Issue And Securities And Services Divsions,
Mumbai Main Branch, Mumbai Samachar Marg, Mumbai, Maharashtra - 400023, India

A11304755

10

90144213

21/04/2009 *

4,725,000,000.00

State Bank of India

Corporate Accounts Group Branch, Voltas House, 23, J.N Heredia Marg, Voltas House, Ballard Estate,
Mumbai, Maharashtra - 400001, India

A63782932

11

90143190

29/12/2000

1,410,000,000.00

State Bank of India

Corporate Accounts Branch, Voltas House; J.N. Her
Edia Marg; Ballard Estate, Mumbai, Maharashtra - 400001, India

-

12

90146062

03/01/2000

1,033,200,000.00

State Bank of India

CAG Branch; Killick House, Charanjit Raj Marg, Mumbai, Maharashtra - 400001, India

-

 

 

 

 

FIXED ASSETS:

 

·         Trademarks / Technical knowhow

·         Software

·         Freehold land

·         Leasehold land

·         Buildings

·         Plant and Machinery

·         Furniture and Fittings

·         Office Equipments

·         Information Technology Equipments

·         Vehicles

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 61.02

UK Pound

1

Rs. 99.99

Euro

1

Rs. 78.37

 

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

DPH

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

7

PAID-UP CAPITAL

1~10

6

OPERATING SCALE

1~10

7

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

6

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

7

--CREDIT LINES

1~10

7

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

YES

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

YES

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

60

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.